Congenital Erythrocytosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-09-20
Clinical Trial Update: Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing [Phase 1]
A Phase 1 clinical trial investigating digoxin for congenital erythrocytosis linked to up-regulated hypoxia sensing has been withdrawn.